During the last session, Zevia PBC (NYSE:ZVIA)’s traded shares were 0.64 million, with the beta value of the company hitting 0.76. At the end of the trading day, the stock’s price was $2.17, reflecting an intraday loss of -2.69% or -$0.06. The 52-week high for the ZVIA share is $4.99, that puts it down -129.95 from that peak though still a striking 71.43% gain since the share price plummeted to a 52-week low of $0.62. The company’s market capitalization is $159.51M, and the average trade volume was 809.10K shares over the past three months.
Zevia PBC (ZVIA) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 2.00. ZVIA has a Sell rating from 1 analyst(s) out of 2 analysts who have looked at this stock. 0 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 1 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be -0.1.
Zevia PBC (NYSE:ZVIA) trade information
Zevia PBC (ZVIA) registered a -2.69% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -2.69% in intraday trading to $2.17, hitting a weekly high. The stock’s 5-day price performance is -11.07%, and it has moved by -40.71% in 30 days. Based on these gigs, the overall price performance for the year is 48.63%.
The consensus price target of analysts on Wall Street is $2, which implies a decrease of -8.5% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $2 and $2 respectively. As a result, ZVIA is trading at a premium of 7.83% off the target high and 7.83% off the low.
Zevia PBC (ZVIA) estimates and forecasts
In the rating firms’ projections, revenue will increase 3.63% compared to the previous financial year.
As companies strive to predict their financial trajectories, we turn our attention to the forthcoming financial quarter. Here are the insights gathered from industry analysts. Revenue for the current quarter is expected to be 37.15M as predicted by 5 analyst(s). Meanwhile, a consensus of 5 analyst(s) estimates revenue growth to 42.41M by the end of current fiscal year. As per earnings report from last fiscal year’s results, sales for the corresponding quarters totaled 38.8M and 40.43M respectively. In this case, analysts expect current quarter sales to shrink by -4.24% and then jump by 4.90% in the coming quarter.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings shrunk an estimated -32.77%. While earnings are projected to return 33.82% in 2025, the next five years will return 35.79% per annum.
ZVIA Dividends
Zevia PBC is due to release its next quarterly earnings in April. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
The next largest institutional holding, with 1.28 million shares, is of VANGUARD GROUP INC’s that is approximately 2.2871% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $0.86 million.
Also, the Mutual Funds coming in first place with the largest holdings of Zevia PBC (ZVIA) shares are Meridian Contrarian Fund and Vanguard Total Stock Market Index Fund . Data provided on Dec 31, 2024 indicates that Meridian Contrarian Fund owns about 1.0 shares. This amounts to just over 1.61 percent of the company’s overall shares, with a $2.17 million market value. The same data shows that the other fund manager holds slightly less at 627.44, or about 1.01% of the stock, which is worth about $1.36 million.
